Looking for leads, investment insights, or competitive intelligence?
News about Amgen
Aimovig apparently cuts migraine days significantly.
Novartis and Amgen want to find out with an experimental drug.
The FDA approved the first cancer medicine "biosimilar" Thursday.
Scientists are ready to move an experimental treatment into phase 1 trials.